First-in-Human Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV367

NCT05507970 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Malaria,Falciparum

Interventions

DRUG: MMV367
DRUG: Placebo
DRUG: MMV367 (Fed 440mg)
DRUG: MMV367
DRUG: Placebo
DRUG: MMV367 (Fasted 440mg)

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]